Logo image of TEAF

TORTOISE SUST&SOCIAL IMP TER (TEAF) Stock Overview

USA - NYSE:TEAF - US27901F1093

12.02 USD
-0.01 (-0.08%)
Last: 9/12/2025, 8:20:00 PM
Fundamental Rating

3

Overall TEAF gets a fundamental rating of 3 out of 10. We evaluated TEAF against 0 industry peers in the Unkown industry. Both the profitability and the financial health of TEAF get a neutral evaluation. Nothing too spectacular is happening here. TEAF has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

In the past year TEAF has reported negative net income.
TEAF had a positive operating cash flow in the past year.
TEAF had positive earnings in 4 of the past 5 years.
Each year in the past 5 years TEAF had a positive operating cash flow.
TEAF Yearly Net Income VS EBIT VS OCF VS FCFTEAF Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 0 -100M -200M

1.2 Ratios

The last Return On Invested Capital (2.37%) for TEAF is above the 3 year average (2.30%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA -4.26%
ROE -5.03%
ROIC 2.37%
ROA(3y)1.33%
ROA(5y)1.92%
ROE(3y)1.57%
ROE(5y)2.21%
ROIC(3y)2.3%
ROIC(5y)2.35%
TEAF Yearly ROA, ROE, ROICTEAF Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 0 5 -5

1.3 Margins

TEAF's Profit Margin has improved in the last couple of years.
In the last couple of years the Operating Margin of TEAF has grown nicely.
In the last couple of years the Gross Margin of TEAF has grown nicely.
Industry RankSector Rank
OM 60.78%
PM (TTM) N/A
GM 64.66%
OM growth 3Y-0.21%
OM growth 5Y5.15%
PM growth 3Y20.78%
PM growth 5YN/A
GM growth 3Y0.22%
GM growth 5Y5.64%
TEAF Yearly Profit, Operating, Gross MarginsTEAF Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 0 100 -100 -200

4

2. Health

2.1 Basic Checks

The number of shares outstanding for TEAF has been reduced compared to 1 year ago.
TEAF has less shares outstanding than it did 5 years ago.
TEAF has a worse debt/assets ratio than last year.
TEAF Yearly Shares OutstandingTEAF Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M
TEAF Yearly Total Debt VS Total AssetsTEAF Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M

2.2 Solvency

TEAF has an Altman-Z score of 2.86. This is not the best score and indicates that TEAF is in the grey zone with still only limited risk for bankruptcy at the moment.
The Debt to FCF ratio of TEAF is 5.93, which is a neutral value as it means it would take TEAF, 5.93 years of fcf income to pay off all of its debts.
TEAF has a Debt/Equity ratio of 0.18. This is a healthy value indicating a solid balance between debt and equity.
Industry RankSector Rank
Debt/Equity 0.18
Debt/FCF 5.93
Altman-Z 2.86
ROIC/WACCN/A
WACCN/A
TEAF Yearly LT Debt VS Equity VS FCFTEAF Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 0 100M -100M 200M -200M

2.3 Liquidity

A Current Ratio of 2.25 indicates that TEAF has no problem at all paying its short term obligations.
TEAF has a Quick Ratio of 2.25. This indicates that TEAF is financially healthy and has no problem in meeting its short term obligations.
Industry RankSector Rank
Current Ratio 2.25
Quick Ratio 2.25
TEAF Yearly Current Assets VS Current LiabilitesTEAF Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 2M 4M 6M

1

3. Growth

3.1 Past

TEAF shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -286.49%.
The Earnings Per Share has been growing by 19.43% on average over the past years. This is quite good.
TEAF shows a decrease in Revenue. In the last year, the revenue decreased by -7.40%.
TEAF shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 7.04% yearly.
EPS 1Y (TTM)-286.49%
EPS 3Y19.43%
EPS 5YN/A
EPS Q2Q%-291.07%
Revenue 1Y (TTM)-7.4%
Revenue growth 3Y-2.29%
Revenue growth 5Y7.04%
Sales Q2Q%-11.9%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
TEAF Yearly Revenue VS EstimatesTEAF Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for TEAF. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
TEAF Price Earnings VS Forward Price EarningsTEAF Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF 31
EV/EBITDA N/A
TEAF Per share dataTEAF EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6 8 10

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

4

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 8.99%, TEAF is a good candidate for dividend investing.
TEAF's Dividend Yield is rather good when compared to the S&P500 average which is at 2.41.
Industry RankSector Rank
Dividend Yield 8.99%

5.2 History

TEAF has been paying a dividend for over 5 years, so it has already some track record.
TEAF has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years3
TEAF Yearly Dividends per shareTEAF Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2024 2025 0.2 0.4 0.6 0.8 1

5.3 Sustainability

TEAF has negative earnings and hence a negative payout ratio. The dividend may be in danger.
DP-168.54%
EPS Next 2YN/A
EPS Next 3YN/A
TEAF Yearly Income VS Free CF VS DividendTEAF Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2019 2020 2021 2022 2023 2024 0 -100M -200M

TORTOISE SUST&SOCIAL IMP TER

NYSE:TEAF (9/12/2025, 8:20:00 PM)

12.02

-0.01 (-0.08%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners39.18%
Inst Owner Change4.13%
Ins Owners0.03%
Ins Owner Change0%
Market Cap162.15M
Analysts0
Price TargetN/A
Short Float %0.13%
Short Ratio0.42
Dividend
Industry RankSector Rank
Dividend Yield 8.99%
Yearly Dividend1.13
Dividend Growth(5Y)N/A
DP-168.54%
Div Incr Years0
Div Non Decr Years3
Ex-Date09-23 2025-09-23 (0.09)
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 15.74
P/FCF 31
P/OCF 31
P/B 0.92
P/tB 0.92
EV/EBITDA N/A
EPS(TTM)-0.69
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0.39
FCFY3.23%
OCF(TTM)0.39
OCFY3.23%
SpS0.76
BVpS13.12
TBVpS13.12
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -4.26%
ROE -5.03%
ROCE 3.01%
ROIC 2.37%
ROICexc 2.37%
ROICexgc 2.37%
OM 60.78%
PM (TTM) N/A
GM 64.66%
FCFM 50.78%
ROA(3y)1.33%
ROA(5y)1.92%
ROE(3y)1.57%
ROE(5y)2.21%
ROIC(3y)2.3%
ROIC(5y)2.35%
ROICexc(3y)2.3%
ROICexc(5y)2.35%
ROICexgc(3y)2.3%
ROICexgc(5y)2.35%
ROCE(3y)2.91%
ROCE(5y)2.97%
ROICexcg growth 3Y0.76%
ROICexcg growth 5Y16.26%
ROICexc growth 3Y0.76%
ROICexc growth 5Y16.26%
OM growth 3Y-0.21%
OM growth 5Y5.15%
PM growth 3Y20.78%
PM growth 5YN/A
GM growth 3Y0.22%
GM growth 5Y5.64%
F-Score2
Asset Turnover0.05
Health
Industry RankSector Rank
Debt/Equity 0.18
Debt/FCF 5.93
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage -3.91
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.25
Quick Ratio 2.25
Altman-Z 2.86
F-Score2
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-286.49%
EPS 3Y19.43%
EPS 5YN/A
EPS Q2Q%-291.07%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-7.4%
Revenue growth 3Y-2.29%
Revenue growth 5Y7.04%
Sales Q2Q%-11.9%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-15.52%
EBIT growth 3Y-2.49%
EBIT growth 5Y12.55%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-66.14%
FCF growth 3Y-27.4%
FCF growth 5YN/A
OCF growth 1Y-66.14%
OCF growth 3Y-27.4%
OCF growth 5YN/A